Amiloride
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| | |
| Amiloride
| |
| Systematic (IUPAC) name | |
| 3,5-diamino-6-chloro-N- (diaminomethylidene)pyrazine-2-carboxamide | |
| Identifiers | |
| CAS number | |
| ATC code | C03 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C6H8ClN7O |
| Mol. mass | 229.627 g/mol |
| Pharmacokinetic data | |
| Bioavailability | Readily absorbed |
| Metabolism | none |
| Half life | 6 to 9 hours |
| Excretion | unchanged in urine |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | oral |
|
WikiDoc Resources for Amiloride | |
|
Articles | |
|---|---|
|
Most recent articles on Amiloride | |
|
Media | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Amiloride at Clinical Trials.gov Clinical Trials on Amiloride at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Amiloride
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Amiloride Discussion groups on Amiloride Directions to Hospitals Treating Amiloride Risk calculators and risk factors for Amiloride
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Amiloride | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Businness | |
|
Experimental / Informatics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Amiloride is a potassium-sparing diuretic, first approved for use in 1967 (then known as MK 870), used in the management of hypertension and congestive heart failure.
Structure
Amiloride is a guanidinium group containing pyrazine derivative.
Mode of action
Amiloride works by directly blocking the epithelial sodium channel (ENaC) thereby inhibiting sodium reabsorption in the distal convoluted tubules and collecting ducts in the kidneys (this mechanism is the same for triamterene). This promotes the loss of sodium and water from the body, but without depleting potassium. The drug is often used in conjunction with thiazide (e.g. co-amilozide) or loop diuretics (e.g. co-amilofruse). Due to its potassium-sparing capacities, hyperkalemia (high blood potassium levels) are occasionally observed in patients taking amiloride. The risk is high in concurrent use of ACE inhibitors or spironolactone. Patients are also advised not to use potassium-containing salt replacements.[1]
A fraction of the effects of amiloride is inhibition of cyclic GMP-gated cation channels in the inner medullary collecting duct.[1]
References
fr:Amiloride hr:Amilorid hu:Amilorid ja:アミロライドth:อะมิโลไรด์
WikiDoc Research Resources for Amiloride (Click show to right to view) | |
|---|---|
| Articles on Amiloride | Most recent articles on Amiloride • Most cited articles on Amiloride • Review articles on Amiloride • Articles on Amiloride in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Amiloride | Powerpoint slides on Amiloride • Images of Amiloride • Photos of Amiloride • Podcasts & MP3s on Amiloride • Videos on Amiloride |
| Evidence Based Medicine Regarding Amiloride | Cochrane Collaboration on Amiloride • Bandolier on Amiloride • TRIP on Amiloride |
| Cost Effectiveness of Amiloride | Cost Effectiveness of Amiloride |
| Clinical Trials Involving Amiloride | Ongoing Trials on Amiloride at Clinical Trials.gov • Trial results on Amiloride • Clinical Trials on Amiloride at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding Amiloride | US National Guidelines Clearinghouse on Amiloride • NICE Guidance on Amiloride • NHS PRODIGY Guidance • FDA on Amiloride • CDC on Amiloride |
| Textbook Information on Amiloride | Books and Textbook Information on Amiloride |
| Pharmacology Resources on Amiloride | Dosing of Amiloride • Drug interactions with Amiloride • Side effects of Amiloride • Allergic reactions to Amiloride • Overdose information on Amiloride • Carcinogenicity information on Amiloride • Amiloride in pregnancy • Pharmacokinetics of Amiloride • |
| Genetics, Pharmacogenomics, and Proteinomics of Amiloride | Genetics of Amiloride • Pharmacogenomics of Amiloride • Proteomics of Amiloride |
| Newstories on Amiloride | Amiloride in the news • Be alerted to news on Amiloride • News trends on Amiloride |
| Commentary on Amiloride | Blogs on Amiloride |
| Patient Resources on Amiloride | Patient resources on Amiloride • Discussion groups on Amiloride • Patient Handouts on Amiloride • Directions to Hospitals Treating Amiloride • Risk calculators and risk factors for Amiloride |
| Healthcare Provider Resources on Amiloride | Symptoms of Amiloride • Causes & Risk Factors for Amiloride • Diagnostic studies for Amiloride • Treatment of Amiloride |
| Continuing Medical Education (CME) Programs on Amiloride | CME Programs on Amiloride |
| International Resources on Amiloride | Amiloride en Espanol • Amiloride en Francais |
| Business Resources on Amiloride | Amiloride in the Marketplace • Patents on Amiloride |
| Informatics Resources on Amiloride | List of terms related to Amiloride |
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

